论著·机制与实践

白藜芦醇通过调控TLR4及其甲基化水平缓解同型半胱氨酸诱导的小鼠胰岛β细胞氧化损伤

  • 海明花 ,
  • 马佳 ,
  • 李心如 ,
  • 罗佳蓉 ,
  • 孙睿 ,
  • 安玉伟 ,
  • 马奔 ,
  • 严若琳 ,
  • 王晨 ,
  • 楚元奎 ,
  • 于欣 ,
  • 马胜超
展开
  • 1.宁夏医科大学 检验学院 (宁夏 银川 750004 )
    3.宁夏医科大学 临床医学院 (宁夏 银川 750004 )
    2.国家卫生健康委代谢性心血管疾病研究重点;实验室 (宁夏 银川 750004 )

收稿日期: 2026-03-09

  网络出版日期: 2026-07-14

基金资助

国家自然科学基金项目(82270492);国家自然科学基金项目(81900273);宁夏医科大学大学生创新创业训练计划(202308124063);宁夏医科大学大学生创新创业训练计划(202408132004)

Resveratrol alleviates homocysteine-induced oxidative damage in mouse pancreatic β-cells by regulating toll-like receptor 4 and its methylation level

  • Minghua HAI ,
  • Jia MA ,
  • Xinru LI ,
  • Jiarong LUO ,
  • Rui SUN ,
  • Yuwei AN ,
  • Ben MA ,
  • Ruolin YAN ,
  • Chen WANG ,
  • Yuankui CHU ,
  • Xin YU ,
  • Shengchao MA
Expand
  • 1.Inspection College,Ningxia Medical University,Yinchuan 750004,Ningxia,China
    3.Key Laboratory of Metabolic Cardiovascular Disease Research of National Health and Wellness Committee,Yinchuan 750004,Ningxia,China
    2.Clinical Medicine College,Ningxia Medical University,Yinchuan 750004,Ningxia,China

Received date: 2026-03-09

  Online published: 2026-07-14

摘要

目的 探讨白藜芦醇(resveratrol, Res)通过调控Toll样受体4(toll-like receptor 4, TLR4)基因及其甲基化水平缓解同型半胱氨酸(homocysteine, Hcy)诱导小鼠胰岛β细胞氧化损伤的机制。 方法 采用CCK-8法检测不同浓度的Hcy和Res对小鼠胰岛β细胞活力的影响;设置分组:对照(Control)组、Hcy组、Hcy + Res共处理组,丙二醛(MDA)试剂盒、谷胱甘肽过氧化物酶(GSH-Px)活性试剂盒、酶联免疫吸附法(ELISA)检测各组细胞MDA水平、GSH-Px活力、胰岛素水平;荧光染色法检测各组细胞氧化应激状态;Western blot和qRT-PCR检测各组细胞TLR4蛋白和mRNA的表达水平;巢式甲基化检测各组细胞TLR4 DNA甲基化表达水平,Western blot检测各组细胞DNA甲基转移酶1(DNMT1)蛋白水平;构建DNMT1小干扰RNA(siRNA)并将其转入胰岛β细胞,设置分组:Hcy组、Hcy + Res组、Hcy + si-NC组、Hcy + si-DNMT1组、Hcy + Res + si-DNMT1组;Western blot检测各组TLR4蛋白水平;采用上述试剂盒检测敲低DNMT1各组MDA水平、GSH-Px活力以及胰岛素水平;构建TLR4 siRNA并将其转入胰岛β细胞的基础上,设置分组:Hcy组、Hcy + si-NC组、Hcy + si-TLR4组、Hcy + Res + si-NC组、Hcy + Res + si-TLR4组,为进一步研究Res自身对TLR4的独立调控作用,增设分组Res + si-NC组、Res + si-TLR4组,采用上述试剂盒检测MDA水平、GSH-Px活力以及胰岛素水平。 结果 用100 μmol/L的Hcy干预后,细胞活力降低,用10 μmol/L的Res干预后,能够有效缓解Hcy对胰岛β细胞的损伤;MDA试剂盒、荧光染色结果显示,与Control组相比,Hcy组MDA和活性氧(ROS)水平升高(P 0.05),Hcy + Res组则下降(P 0.05),GSH-Px活性试剂盒、ELISA法结果显示,与Control组相比,Hcy组GSH-Px活性和胰岛素水平降低(P 0.05),Hcy + Res组则升高(P 0.05);Western blot和qRT-PCR结果显示,与Control组相比,Hcy组细胞TLR4蛋白水平、mRNA水平显著升高(P 0.05),Hcy + Res组则显著下降(P 0.05),而巢式甲基化结果显示,TLR4甲基化水平与mRNA表达呈负相关;相较于Control组,DNMT1的蛋白水平在Hcy组中低表达(P 0.05),在Hcy + Res组中高表达(P 0.05);与Hcy + si-NC组相比,Hcy + si-DNMT1组TLR4蛋白表达显著升高(P 0.05),与Hcy + Res组相比,Hcy + Res+si-DNMT1组TLR4蛋白表达进一步升高(P 0.05);与Hcy + si-NC组相比,Hcy + si-DNMT1组MDA水平显著升高(P 0.05),与Hcy + Res组相比,Hcy + Res + si-DNMT1组MDA水平进一步升高(P 0.05);而GSH-Px活力、胰岛素水平变化方向与MDA变化相反;进一步敲低TLR4后MDA水平下降(P 0.05),Res干预后则更低(P 0.05);而GSH-PX活性和胰岛素水平升高(P 0.05),Res干预后则更高(P 0.05)。 结论 Res能够减轻Hcy诱导的胰岛β细胞氧化损伤,这一过程与TLR4表达及其甲基化水平改变有关。

本文引用格式

海明花 , 马佳 , 李心如 , 罗佳蓉 , 孙睿 , 安玉伟 , 马奔 , 严若琳 , 王晨 , 楚元奎 , 于欣 , 马胜超 . 白藜芦醇通过调控TLR4及其甲基化水平缓解同型半胱氨酸诱导的小鼠胰岛β细胞氧化损伤[J]. 实用医学杂志, 2026 , 42(13) : 2428 -2437 . DOI: 10.3969/j.issn.1006-5725.2026.13.019

Abstract

Objective This study aims to explore the mechanism through which resveratrol (Res) mitigates homocysteine (Hcy)-induced oxidative damage in mouse pancreatic β-cells by regulating the expression and methylation level of the Toll-like receptor 4 (TLR4) gene. Methods The effects of different concentrations of homocysteine and resveratrol on the viability of mouse pancreatic β-cells were evaluated using the CCK-8 assay. In each group, the levels of malondialdehyde (MDA), the activity of glutathione peroxidase (GSH-Px), and the levels of insulin were measured using an MDA kit, a GSH-Px activity kit, and enzyme-linked immunosorbent assay (ELISA), respectively. The oxidative stress status was assessed through fluorescence staining. The protein and mRNA expression levels of TLR4 in the control group, the Hcy group, and the homocysteine + resveratrol (Hcy + Res) co-treatment group were detected via Western blot and qRT-PCR. The DNA methylation level of TLR4 was determined using nested methylation-specific PCR, and the protein expression of DNMT1 (DNA methyltransferase 1) was measured by Western blot. Small interfering RNA fragments targeting DNMT1 were constructed and transfected into pancreatic β-cells. Subsequently, the TLR4 protein expression was detected by Western blot. The MDA levels, GSH-Px activity, and insulin levels in the DNMT1 knockdown groups were measured using the aforementioned kits. Likewise, small interfering RNA fragments targeting TLR4 were constructed and transfected into pancreatic β-cells, and then the MDA levels, GSH-Px activity, and insulin levels were measured. Results Cell viability decreased after treatment with 100 μmol/L Hcy. In contrast, intervention with 10 μmol/L Res effectively mitigated the Hcy-induced damage to pancreatic β-cells. Results from the MDA assay and fluorescence staining indicated that, when compared with the Control group, the Hcy group had elevated MDA and reactive oxygen species (ROS) levels (P 0.05), while these levels declined in the Hcy+Res group (P 0.05). Findings from the GSH-Px activity assay and ELISA demonstrated that, relative to the Control group, the Hcy group had reduced GSH-Px activity and insulin levels (P 0.05), whereas the Hcy + Res group showed increased levels (P 0.05). Western blot and qRT-PCR results showed that the expression levels of TLR4 protein and mRNA were significantly higher in the Hcy group than in the Control group (P 0.05), while they were significantly lower in the Hcy + Res group (P 0.05). Conversely, results from nested methylation-specific PCR showed that the TLR4 DNA methylation levels displayed an opposite trend. The expression of DNMT1 protein was lower in the Hcy group (P 0.05) and higher in the Hcy + Res group (P 0.05) compared with the Control group. The expression of TLR4 protein was significantly higher in the Hcy + si-DNMT1 group than in the Hcy + si-NC group (P 0.05), and it was further increased in the Hcy + Res + si-DNMT1 group compared with the Hcy + Res group (P 0.05). Compared with the Hcy + si-NC group, the MDA levels were significantly elevated in the Hcy + si-DNMT1 group (P 0.05). Moreover, when compared with the Hcy + Res group, the MDA levels were further increased in the Hcy + Res + si-DNMT1 group (P 0.05). The changes in GSH-Px activity and insulin levels were opposite to those of MDA. Further knockdown of TLR4 led to a decrease in MDA levels (P 0.05), and there was an even greater reduction after Res intervention (P 0.05). Conversely, GSH-Px activity and insulin levels increased (P 0.05), and there was a further elevation after Res intervention (P 0.05). Conclusion Resveratrol alleviates the oxidative damage in pancreatic β-cells induced by homocysteine, a process that is associated with alterations in TLR4 expression and its methylation level.

参考文献

[1] INAISHI J, SAISHO Y. Beta-cell mass in obesity and type 2 diabetes, and its relation to pancreas fat: A mini-review[J]. Nutrients, 2020, 12(12): 3846. doi:10.3390/nu12123846 .
[2] 李利函, 王善龙, 宋影. 血清Hcy、25-OH-D3、SF水平与2型糖尿病患者胰岛素抵抗的关系[J]. 黑龙江医药科学, 2026, 49(2): 76-78. doi:10.3969/j.issn.1008-0104.2026.02.024 .
[3] 马凌桔,汪乐新,迟宏扬,等.METTL3在同型半胱氨酸诱导小鼠胰岛β细胞自噬中的作用[J].中国组织工程研究,2024,28(26):4221-4225.doi: 10.12307/2024.423
[4] YU X, JIA Y, REN F. Multidimensional biological activities of resveratrol and its prospects and challenges in the health field[J]. Front Nutr, 2024, 11: 1408651. doi:10.3389/fnut.2024. 1408651 .
[5] GONG W, LI J, CHEN W, et al. Resveratrol inhibits lipopolysaccharide-induced extracellular matrix accumulation and inflammation in rat glomerular mesangial cells by SphK1/S1P2/NF-κB pathway[J]. Diabetes Metab Syndr Obes Targets Ther, 2020, 13: 4495-4505. doi:10.2147/dmso.s278267 .
[6] CRAMMOND P, HASTAK P, DELANEY A,et al. Taking its TOLL: the role of toll-like receptor 4 in human health and disease, and its potential as a therapeutic target[J].Front Immunol,2026,17:1761361. doi: 10.3389/fimmu.2026.1761361. eCollection 2026 .
[7] LAN C, LI Y, WENG Z, et al. TLR4 mediates lipotoxic β-cell dysfunction by inhibiting the TMEM24/PI3K/AKT pathway[J]. Acta Biochim Biophys Sin, 2025, 57(10): 1684-1695. doi:10.3724/abbs.2025045 .
[8] CHEN J, FEI S, CHAN L W C, et al. Inflammatory signaling pathways in pancreatic β-cell: New insights into type 2 diabetes pathogenesis[J]. Pharmacol Res, 2025, 216: 107776. doi:10.1016/j.phrs.2025.107776 .
[9] CRAMMOND P, HASTAK P, DELANEY A, et al. Taking its TOLL: The role of toll-like receptor 4 in human health and disease, and its potential as a therapeutic target[J]. Front Immunol, 2026, 17: 1761361. doi:10.3389/fimmu.2026.1761361 .
[10] 高艳. TLR4基因甲基化对酒精性脂肪性肝炎痰瘀互结证发病机制的影响[D]. 太原: 山西中医药大学, 2021.
[11] DING T, WEN B, CHEN J, et al. Excess homocysteine inhibits pancreatic β-cell secretory function by repressing Zbtb20 expression[J]. Mol Cell Endocrinol, 2024, 586: 112195. doi:10.1016/j.mce.2024.112195 .
[12] 邓玲,梁瑜祯,铁死亡与胰岛β细胞功能的研究进展.中华内科杂志,2023,62(1) : 113-116. DOI: 10.3760/cma.j.cn112138-20220502-00333 .
[13] CRUCIANI-GUGLIELMACCI C, MENEYROL K, DENOM J, et al. Homocysteine metabolism pathway is involved in the control of glucose homeostasis: A cystathionine beta synthase deficiency study in mouse[J]. Cells, 2022, 11(11): 1737. doi:10.3390/cells11111737 .
[14] ZHANG X, QU Y Y, LIU L, et al. Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation[J]. Cell Rep, 2021, 37(2): 109821. doi:10.1016/j.celrep.2021.109821 .
[15] YUAN X, DING S, ZHOU L, et al. Association between plasma homocysteine levels and pancreatic islet beta-cell function in the patients with type 2 diabetes mellitus: A cross-sectional study from China[J]. Ann Palliat Med, 2021, 10(7): 8169-8179. doi:10.21037/apm-21-1671 .
[16] LI Y, ZHANG H, JIANG C, et al. Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue[J]. J Biol Chem, 2013, 288(14): 9583-9592. doi:10.1074/jbc.M112.431627 .
[17] STANCILL J S, CORBETT J A. The role of thioredoxin/peroxiredoxin in the β-cell defense against oxidative damage[J]. Front Endocrinol, 2021, 12: 718235. doi:10.3389/fendo.2021. 718235 .
[18] LENZEN S. The pancreatic beta cell: An intricate relation between anatomical structure, the signalling mechanism of glucose-induced insulin secretion, the low antioxidative defence, the high vulnerability and sensitivity to diabetic stress[J]. ChemTexts, 2021, 7(2): 13. doi:10.1007/s40828-021-00140-3 .
[19] XUAN Y, YANG Y, SUN Y, et al. Antagonistic effects of resveratrol on reproductive injury in hind-limp unloading male rats[J]. Kjkxxb, 2024, 44(1): 133. doi:10.11728/cjss2024.01.2023-0063 .
[20] PELCZY?SKA M, SZYMON S, KONIECZNY M, et al. Influence of certain natural bioactive compounds on glycemic control: A narrative review[J]. Nutrients, 2026, 18(1): 52. doi:10.3390/nu18010052 .
[21] KOGUT ?, PUCHALSKI C, KATRY?SKA D, et al. The Multidirectional Biological Activity of Resveratrol: Molecular Mechanisms, Systemic Effects and Therapeutic Potential-A Review[J].Nutrients, 2026,18(2):313. doi: 10.3390/nu18020313 .
[22] VELA-GUAJARDO J E, GARZA-GONZáLEZ S, GARCíA N. Glucolipotoxicity-induced oxidative stress is related to mitochondrial dysfunction and apoptosis of pancreatic β-cell[J]. Curr Diabetes Rev, 2021, 17(5): e031120187541. doi:10.2174/1573399816666201103142102 .
[23] EGUCHI N, VAZIRI N D, DAFOE D C, et al. The role of oxidative stress in pancreatic β cell dysfunction in diabetes[J]. Int J Mol Sci, 2021, 22(4): 1509. doi:10.3390/ijms22041509 .
[24] DINI? S, ARAMBA?I? JOVANOVI? J, USKOKOVI? A, et al. Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management[J]. Front Endocrinol, 2022, 13: 1006376. doi:10.3389/fendo.2022.1006376 .
[25] ZHANG Y, LIANG X, BAO X, et al. Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective[J]. Eur J Med Chem, 2022, 235: 114291. doi:10.1016/j.ejmech.2022. 114291 .
[26] ZENG F, ZHENG J, SHEN L, et al. Physiological mechanisms of TLR4 in glucolipid metabolism regulation: Potential use in metabolic syndrome prevention[J]. Nutr Metab Cardiovasc Dis, 2023, 33(1): 38-46. doi:10.1016/j.numecd.2022.10.011 .
[27] WANG X, LI K, TANG J. Acute glucose load induced islet β cells dysfunction in TLR4 dependent manner in male mice[J]. Biochem Biophys Res Commun, 2020, 524(1): 205-210. doi:10.1016/j.bbrc.2020.01.059 .
[28] KOKLESOVA L, MAZURAKOVA A, SAMEC M, et al. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person[J]. EPMA J, 2021, 12(4): 477-505. doi:10.1007/s13167-021-00263-0 .
[29] 农茜, 陆文权, 梁烨, 等. 同型半胱氨酸与甲基代谢及其胱硫醚酶基因研究进展[J]. 临床医学进展, 2020, 10(7): 1277-1284. doi:10.12677/ACM.2020.107194 .
[30] MOHAN K N. DNMT1: Catalytic and non-catalytic roles in different biological processes[J]. Epigenomics, 2022, 14(10): 629-643. doi:10.2217/epi-2022-0035 .
[31] REN W, GAO L, SONG J. Structural basis of DNMT1 and DNMT3A-mediated DNA methylation[J]. Genes, 2018, 9(12): 620. doi:10.3390/genes9120620 .
[32] MOHAN K N, CHAILLET J R. Cell and molecular biology of DNA methyltransferase 1[J]. Int Rev Cell Mol Biol, 2013, 306: 1-42. doi: 10.1016/B978-0-12-407694-5.00001-8 .
[33] SINGH M, SAXENA S, MOHAN K N. DNMT1 downregulation as well as its overexpression distinctly affect mostly overlapping genes implicated in schizophrenia, autism spectrum, epilepsy, and bipolar disorders[J]. Front Mol Neurosci, 2023, 16: 1275697. doi:10.3389/fnmol.2023.1275697 .
[34] ELDER E, LEMIEUX A, LEGAULT L M, et al. Rescuing DNMT1 fails to fully reverse the molecular and functional repercussions of its loss in mouse embryonic stem cells[J]. Nucleic Acids Res, 2025, 53(4): gkaf130. doi:10.1093/nar/gkaf130 .
[35] ZHAO Z, LI L, ZENG R, et al. 5mC modification orchestrates choriogenesis and fertilization by preventing prolonged ftz-f1 expression[J]. Nat Commun, 2023, 14(1): 8234. doi:10.1038/s41467-023-43987-5 .
文章导航

/